- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02891330
Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity (IRCO)
April 20, 2021 updated by: University Hospital, Lille
Assessing the Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity With the Risk of Occurrence of Dumping Syndrome After Gastric Bypass.
The postprandial dumping syndrome is a frequent consequence of Roux-en-Y Gastric ByPass due to the rapid emptying of the stomach remnant in to the intestinal lumen.
Dumping-related symptoms occur very early after eating (within 30 minutes), are not associated with concurrent hypoglycemia, and are most prominent in the early postoperative period.
This syndrome very debilitating for the patient can be improved by dietary and nutritional recommendations.
We hypothesize that a personalized approach based on dietary and nutritional recommendations conducted by a nurse would likely to decrease the frequency of dumping syndrome and improve the postoperative quality of life of patients in the early postoperative period.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The Roux-en-Y Gastric ByPass is considered the gold standard of weight loss surgery and is the most commonly performed bariatric procedure worldwide.The postprandial dumping syndrome is a frequent consequence of gastrojejunal anastomosis due to the rapid emptying of the stomach remnant in to the intestinal lumen.
Dumping-related symptoms occur very early after eating (within 30 minutes), are not associated with concurrent hypoglycemia, and are most prominent in the early postoperative period.
The symptoms of dumping syndrome include nausea, abdominal cramps, diarrhea, dizzy spells, weakness and cold sweats either with or after eating.This syndrome very debilitating for the patient can be improved by dietary and nutritional recommendations.
We hypothesize that an individualized approach based on dietary and nutritional recommendations and monitoring of patients conducted by a nurse in the first three months after surgery would likely to decrease these problems and improve the postoperative quality of life of patients.
Study Type
Interventional
Enrollment (Actual)
135
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Arras, France
- CH ARRAS
-
Boulogne Sur Mer, France, 62321
- Ch Boulogne-Sur-Mer
-
Lille, France
- Hôpital Claude Huriez, CHRU
-
Valenciennes, France
- Ch de Valenciennes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Body Mass Index ≥40 kg / m2 or ≥35 kg / m2 in the presence of comorbidities related to obesity
- Indication to Roux-en-Y Gastric ByPass
Exclusion Criteria:
- Contraindication to Roux-en-Y Gastric ByPass
- Refusal to sign the consent form
- Patient not affiliated to a social security system
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dietary and nutritional recommendations
Postoperative personalized approach based on dietary and nutritional recommendations conducted by a nurse
|
Supplementary dietary and nutritional education
|
|
No Intervention: Standard of care
Postoperative standard of care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The frequency of dumping syndrome
Time Frame: 3 months
|
The frequency of dumping syndrome at 3 months will be compared between the two groups.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Body Mass Index
Time Frame: 3 months
|
3 months
|
|
|
Frequence of Adverse Events after surgery
Time Frame: at 1 and 3 months
|
at 1 and 3 months
|
|
|
Quality of Life-Lite questionnaire
Time Frame: 3 months
|
Estimation of quality of life by Impact of Weight on Quality of Life-Lite questionnaire(IWQOL-Lite)
|
3 months
|
|
Personal Effectiveness Assessment questionnaire (SEPOB)
Time Frame: 3 months
|
Measure the efficacy of therapeutic education by personal estimation of the level of skill using a specific obesity assessment questionnaire (SEPOB questionnaire or survey emotional, cognitive and behavioral sense of personal efficacy)
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hélène VERKINDT, MD, University Hospital, Lille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 2, 2017
Primary Completion (Actual)
December 18, 2020
Study Completion (Actual)
December 18, 2020
Study Registration Dates
First Submitted
September 1, 2016
First Submitted That Met QC Criteria
September 1, 2016
First Posted (Estimate)
September 7, 2016
Study Record Updates
Last Update Posted (Actual)
April 21, 2021
Last Update Submitted That Met QC Criteria
April 20, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014_17
- 2015-A00646-43 (Other Identifier: ID-RCB number, ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dumping Syndrome
-
Universitaire Ziekenhuizen KU LeuvenCompletedPostoperative Dumping SyndromeBelgium
-
University Hospital, Basel, SwitzerlandCompletedBariatric Surgery | Postprandial Hypoglycemia | Late Dumping SyndromeSwitzerland
-
Radboud University Medical CenterUnknown
-
Technological Educational Institute of ThessalyRecruiting
-
Universitaire Ziekenhuizen KU LeuvenIpsenCompleted
-
Novartis PharmaceuticalsCompletedDumping SyndromeBelgium, Netherlands, Germany, France, United States
-
Larissa University HospitalRecruitingDumping Syndrome | Gastric SurgeryGreece
-
Samsung Medical CenterRecruitingDumping Syndrome | Esophagectomy | Continous Glucose MeasurementSouth Korea
-
Cambridge University Hospitals NHS Foundation TrustCompleted
-
University Hospital Inselspital, BerneCompletedDumping Syndrome | Hypoglycemia, ReactiveSwitzerland
Clinical Trials on Dietary and nutritional recommendations conducted by a nurse
-
Fundación Pública Andaluza para la Investigación...CompletedMalnutrition | End Stage Renal DiseaseSpain
-
Umeå UniversityCompleted
-
Asia Diabetes FoundationCompleted
-
Pontificia Universidad Catolica de ValparaisoCompleted
-
KU LeuvenCompletedHeart FailureBelgium
-
Olympic Seafood ASCompletedAdverse Drug Event | Side Effects of DrugsFinland
-
AGIR à DomTerminatedALS | Charcot DiseaseFrance
-
Hôpital NOVOActive, not recruiting
-
Uppsala UniversityVästmanland County Council, SwedenCompleted
-
St George's, University of LondonThe Stroke Association, United KingdomCompleted